COMMUNIQUÉ DE PRESSE publié le 22/07/2024 à 14:00, il y a 1 année 10 mois MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRÈVE publiée le 15/07/2024 à 13:05, il y a 1 année 11 mois Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
BRÈVE publiée le 15/07/2024 à 13:05, il y a 1 année 11 mois Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
COMMUNIQUÉ DE PRESSE publié le 15/07/2024 à 13:00, il y a 1 année 11 mois Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders
Publié le 15/06/2026 à 23:00, il y a 27 minutes BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Publié le 15/06/2026 à 23:00, il y a 27 minutes Biophytis annonce la suspension provisoire de la cotation de son action
Publié le 15/06/2026 à 18:57, il y a 4 heures 30 minutes Reporting on share buyback transactions carried out between June 8 and June 11, 2026
Publié le 15/06/2026 à 18:57, il y a 4 heures 30 minutes Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 8 au 11 juin 2026
Publié le 15/06/2026 à 18:32, il y a 4 heures 55 minutes Edenred strengthens its electric charging offering with the acquisition of The Mobility House Solutions
Publié le 15/06/2026 à 23:15, il y a 12 minutes Petrolympic Announces Results From 2026 Winter Program on Rayon D'or and Vauquelin Gold and Base Metals Property in Val-d'Or, Quebec
Publié le 15/06/2026 à 23:01, il y a 26 minutes Gemdale Gold Expands Land Position in Finland and Recommences Exploration in the Central Lapland Greenstone Belt
Publié le 15/06/2026 à 23:00, il y a 27 minutes Galantas Announces Shareholder Approval of Acquisition of Sol De Oro and Appointment of Chief Financial Officer
Publié le 15/06/2026 à 15:00, il y a 8 heures 27 minutes PPX Mining Announces Additional Convertible Debenture Conversion by Rivi Opportunity Fund
Publié le 15/06/2026 à 14:30, il y a 8 heures 57 minutes As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR Congo
Publié le 15/06/2026 à 22:48, il y a 39 minutes Siltronic AG successfully completes a capital increase with gross proceeds of EUR 273 million to support long-term growth and strengthen balance sheet
Publié le 15/06/2026 à 22:44, il y a 43 minutes EQS-Adhoc: Siltronic AG: Siltronic AG successfully places new shares in the amount of 10 percent of the share capital at EUR 91 per share
Publié le 15/06/2026 à 20:55, il y a 2 heures 32 minutes Sopra Steria extends strategic collaboration with Red Hat to industrialise sovereign-ready embedded AI
Publié le 15/06/2026 à 18:57, il y a 4 heures 30 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 15/06/2026 à 18:45, il y a 4 heures 42 minutes TAG Immobilien AG: 25.6% of shareholders opt for scrip dividend